Methotrexate.
Chorionic carcinoma of the uterus, acute lymphocytic leukemia, tumors of the central nervous system (leukemoid infiltration of the meninges), breast cancer, head and neck cancer, cancer of the lungs, bladder, stomach; Hodgkin’s disease, non-Hodgkin’s lymphoma, retinoblastoma, osteosarcoma, Ewing’s sarcoma, soft tissue sarcoma; refractory psoriasis.
Active ingredient: methotrexate 2.5 mg
Prescription medicine.